ANVISA-2020-0005-V405
Type II variation for application ANVISA-2020-0005. Type II variation: Specification Change for Haemoferrin — critical change
Variation Number
ANVISA-2020-0005-V405
Type
Type II
Application
Change
Status
Blocked
Fee
€74,542
Submitted
2023-02-25
Approved
—
Description
Type II variation: Specification Change for Haemoferrin — critical change